Bionano Genomics, Inc.
BNGO
$3.65
-$0.05-1.35%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 18.23M | 9.48M | 11.95M | 18.94M | 28.32M |
| Total Receivables | 3.35M | 4.77M | 5.62M | 6.36M | 8.51M |
| Inventory | 9.56M | 11.12M | 14.32M | 19.48M | 19.59M |
| Prepaid Expenses | 2.78M | 703.00K | 4.09M | 4.79M | 4.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 11.00M | 13.42M | 11.00M | 11.01M | 24.45M |
| Total Current Assets | 44.93M | 39.49M | 46.98M | 60.57M | 85.61M |
|
|
|||||
| Total Current Assets | 44.93M | 39.49M | 46.98M | 60.57M | 85.61M |
| Net Property, Plant & Equipment | 22.70M | 24.32M | 26.18M | 32.49M | 33.60M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 8.37M | 9.71M | 11.05M | 30.02M | 31.73M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 2.42M | 3.15M | 3.16M | 6.29M | 7.05M |
| Total Assets | 78.41M | 76.67M | 87.36M | 129.36M | 158.00M |
|
|
|||||
| Total Accounts Payable | 6.56M | 6.96M | 8.70M | 8.73M | 9.84M |
| Total Accrued Expenses | 2.71M | 4.62M | 4.60M | 3.80M | 5.86M |
| Short-term Debt | 13.04M | 20.36M | 14.95M | 19.36M | 29.08M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.85M | 3.25M | 2.22M | 2.41M | 2.46M |
| Total Finance Division Other Current Liabilities | 2.25M | 2.15M | 2.47M | 2.87M | 11.26M |
| Total Other Current Liabilities | 2.25M | 2.15M | 2.47M | 2.87M | 11.26M |
| Total Current Liabilities | 26.41M | 37.34M | 32.95M | 37.18M | 58.51M |
|
|
|||||
| Total Current Liabilities | 26.41M | 37.34M | 32.95M | 37.18M | 58.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 13.04M | 20.36M | 14.95M | 19.36M | 29.08M |
| Capital Leases | 3.53M | 3.68M | 5.28M | 5.81M | 6.33M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 292.00K | 267.00K | 263.00K | 6.05M | 10.39M |
| Total Liabilities | 30.23M | 41.30M | 38.49M | 49.03M | 75.22M |
|
|
|||||
| Common Stock & APIC | 744.50M | 728.57M | 720.43M | 709.19M | 695.42M |
| Retained Earnings | -696.33M | -693.23M | -673.10M | -628.85M | -612.63M |
| Treasury Stock & Other | 14.00K | 27.00K | 1.53M | -3.00K | -16.00K |
| Total Common Equity | 48.19M | 35.38M | 48.87M | 80.34M | 82.77M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 48.19M | 35.38M | 48.87M | 80.34M | 82.77M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 48.19M | 35.38M | 48.87M | 80.34M | 82.77M |
|
|
|||||